Published in Urology on February 01, 2005
A meta-analysis of kidney microarray datasets: investigation of cytokine gene detection and correlation with rt-PCR and detection thresholds. BMC Genomics (2007) 0.98
RCDB: Renal Cancer Gene Database. BMC Res Notes (2012) 0.95
Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41
Signatures of mutation and selection in the cancer genome. Nature (2010) 9.75
Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res (2005) 7.66
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study. Lancet Oncol (2013) 3.19
Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study. Lancet Oncol (2012) 2.84
An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell (2011) 2.78
Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations. Surgery (2008) 2.26
VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Mol Cell Biol (2006) 2.03
Regulation of endocytosis via the oxygen-sensing pathway. Nat Med (2009) 2.00
Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney are the same disease entity: molecular and histologic evidence. Am J Surg Pathol (2009) 1.84
Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature. Am J Surg Pathol (2008) 1.70
Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study. Mol Cancer Ther (2010) 1.70
Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. J Biol Chem (2005) 1.64
The investigational Aurora kinase A inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivo. Clin Cancer Res (2013) 1.62
A molecular classification of papillary renal cell carcinoma. Cancer Res (2005) 1.60
Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy. Cancer (2010) 1.52
Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles. Cancer Res (2004) 1.47
Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol (2011) 1.38
The E2F3-Oncomir-1 axis is activated in Wilms' tumor. Cancer Res (2008) 1.33
Parafibromin inhibits cancer cell growth and causes G1 phase arrest. Biochem Biophys Res Commun (2006) 1.25
Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma. Am J Surg Pathol (2007) 1.22
Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response. PLoS Genet (2008) 1.20
Functional importance of Dicer protein in the adaptive cellular response to hypoxia. J Biol Chem (2012) 1.15
Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma. J Med Genet (2011) 1.14
Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clin Cancer Res (2007) 1.10
Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinoma. Clin Cancer Res (2005) 1.09
Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients. Clin Cancer Res (2004) 1.06
Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression. BMC Med Genomics (2010) 1.06
Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas. Proc Natl Acad Sci U S A (2011) 1.05
Prospective clinical trial of preoperative sunitinib in patients with renal cell carcinoma. J Urol (2010) 1.04
Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder. BMC Med Genomics (2010) 1.03
Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer. Clin Cancer Res (2009) 0.98
Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma. Hum Pathol (2006) 0.98
VX680/MK-0457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma. Am J Transl Res (2010) 0.98
Folliculin interacts with p0071 (plakophilin-4) and deficiency is associated with disordered RhoA signalling, epithelial polarization and cytokinesis. Hum Mol Genet (2012) 0.98
Prognostic factors in patients with diffuse large B cell lymphoma: Before and after the introduction of rituximab. Leuk Lymphoma (2008) 0.98
Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma. Cancer (2012) 0.97
Identification of copy number alterations and its association with pathological features in clear cell and papillary RCC. Cancer Lett (2008) 0.96
The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients. Target Oncol (2013) 0.95
Maximizing RNA yield from archival renal tumors and optimizing gene expression analysis. J Biomol Screen (2009) 0.94
Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab (2008) 0.94
Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype. Cancer Res (2004) 0.93
Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets. Cancer Res (2011) 0.90
The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA. Mol Carcinog (2010) 0.89
Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeek). Clin Cancer Res (2005) 0.89
Role of sunitinib and SU12662 on dermatological toxicities in metastatic renal cell carcinoma patients: in vitro, in vivo, and outcomes investigation. Cancer Chemother Pharmacol (2013) 0.89
CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors. Endocr Relat Cancer (2010) 0.88
Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Anal Quant Cytol Histol (2006) 0.88
Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new. Lancet Oncol (2010) 0.87
Elucidation of the molecular signatures of renal cell carcinoma by gene expression profiling. J Med Invest (2006) 0.87
Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma. Mod Pathol (2011) 0.86
Overexpression of glutathione s-transferase alpha in clear cell renal cell carcinoma. Am J Clin Pathol (2005) 0.85
Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer tumorigenesis. Cancer Biol Ther (2008) 0.85
8q24 and 17q prostate cancer susceptibility loci in a multiethnic Asian cohort. Urol Oncol (2012) 0.85
Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma. Am J Surg Pathol (2004) 0.85
Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinoma. Am J Pathol (2011) 0.84
An association between transient hypokalemia and severe acute oxaliplatin-related toxicity predominantly in women. Acta Oncol (2010) 0.84
A unique case of spontaneous regression of metastatic papillary renal cell carcinoma: a case report. Cases J (2009) 0.84
Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma. Am J Clin Pathol (2006) 0.83
Molecular targets on the horizon for kidney and urothelial cancer. Nat Rev Clin Oncol (2013) 0.82
Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics. Adv Cancer Res (2003) 0.82
Gastrointestinal stromal tumour in the elderly. Crit Rev Oncol Hematol (2008) 0.82
Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion. J Clin Endocrinol Metab (2014) 0.81
Nasal metastases from renal cell carcinoma are associated with Memorial Sloan-Kettering Cancer Center poor-prognosis classification. Chin J Cancer (2011) 0.81
Spectral karyotyping of sarcomas and fibroblasts derived from Ink4a/Arf-deficient mice reveals chromosomal instability in vitro. Int J Oncol (2005) 0.80
Novel genetic aberrations in breast phyllodes tumours: comparison between prognostically distinct groups. Breast Cancer Res Treat (2014) 0.80
Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism. Am J Pathol (2002) 0.80
From tissue phenotype to proteotype: sensitive protein identification in microdissected tumor tissue. Int J Oncol (2006) 0.80
A comparison study reveals important features of agreement and disagreement between summarized DNA and RNA data obtained from renal cell carcinoma. Mutat Res (2008) 0.79
Predictive models for the practical management of renal cell carcinoma. Nat Rev Urol (2012) 0.79
Race to report: are vascular endothelial growth factor genetic polymorphisms associated with outcome in advanced breast cancer patients treated with Paclitaxel plus bevacizumab? J Clin Oncol (2009) 0.78
Stage T1N0M0 renal cell carcinoma: the prognosis in Asian patients. Chin J Cancer (2011) 0.78
Correction: The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma. PLoS One (2015) 0.78
Glypican 3 overexpression in primary and metastatic Wilms tumors. Virchows Arch (2014) 0.78
Gene profiling suggests a common evolution of bladder cancer subtypes. BMC Med Genomics (2013) 0.77
Microarray gene expression profiling using core biopsies of renal neoplasia. Am J Transl Res (2009) 0.76
Predictive molecular biomarkers to guide clinical decision making in kidney cancer: current progress and future challenges. Expert Rev Mol Diagn (2015) 0.76
Dual KS: Defining Gene Sets with Tissue Set Enrichment Analysis. Cancer Inform (2010) 0.76
Association of drug exposure with toxicity and clinical response in metastatic renal cell carcinoma patients receiving an attenuated dosing regimen of sunitinib. Target Oncol (2014) 0.76
Association between being underweight and outcomes in breast cancer: alternative explanations. J Clin Oncol (2010) 0.75
Papillary renal cell carcinoma with metastatic laparoscopic port site and vaginal involvement: a case report. J Med Case Rep (2011) 0.75
HRPT2 and parathyroid cancer. Lancet Oncol (2004) 0.75
'Prechronous' metastasis in clear cell renal cell carcinoma: a case report. J Med Case Rep (2011) 0.75
Corrigendum: Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity. Sci Rep (2017) 0.75
Exploring the benefits of early access to palliative care in advanced lung cancer: living better, living longer, or both? J Clin Oncol (2012) 0.75
Outcomes of Dose-Attenuated Docetaxel in Asian Patients with Castrate-Resistant Prostate Cancer. Ann Acad Med Singapore (2017) 0.75
A multimodality approach to reversible paraneoplastic encephalitis associated with ovarian teratomas. Acta Oncol (2009) 0.75